<DOC>
	<DOCNO>NCT00149539</DOCNO>
	<brief_summary>Buprenorphine treatment opioid dependence . Naloxone give addition buprenorphine order limit abuse potential commonly associate buprenorphine . The purpose study determine abuse potential high dos buprenorphine/naloxone opioid dependent individual .</brief_summary>
	<brief_title>Abuse Potential Buprenorphine/Naloxone</brief_title>
	<detailed_description>Buprenorphine , mixed agonist-antagonist opioid ( partial agonist ) , safe effective treatment opioid dependence . However , concern buprenorphine may abuse due high abuse potential . A sublingual buprenorphine/naloxone combination tablet may reduce risk abuse associate buprenorphine alone . The purpose study determine abuse potential acute dose buprenorphine/naloxone individual maintain different daily dos sublingual buprenorphine/naloxone . Participants maintain low high dos buprenorphine/naloxone . They challenge low- high-dose injected buprenorphine/naloxone , well active placebo control maintenance dose . During study visit , physiologic , subjective , psychomotor response challenge session monitor compare know pharmacologic effect opioid drug .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Naloxone</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<mesh_term>Buprenorphine , Naloxone Drug Combination</mesh_term>
	<criteria>Actively abuse illegal opioids Qualifies opioid substitution treatment ( e.g. , methadone buprenorphine ) , active treatment time study entry Meets DSMIV criterion opioid dependence Significant medical problem ( e.g. , insulin dependent diabetes mellitus ) Nonsubstance use psychiatric disorder ( e.g. , schizophrenia ) Seeking substance abuse treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2007</verification_date>
</DOC>